Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2025-12-24 @ 2:54 PM
NCT ID:
NCT05691959
Eligibility Criteria:
Inclusion Criteria: Diagnosis of atrial fibrillation with rapid ventricular response (ventricular rate over 100 bpm) due to an electrophysiologic etiology.
\-
Exclusion Criteria:
1. Unstable, requiring electric cardioversion -hypotensive
* altered mental status
* myocardial infarction
* pulmonary hypertension
2. Patients at risk of hypercalcemia - renal failure
3. Know cardiac valvular disease
4. Allergic to calcium gluconate or diltiazem
5. Underlying cardiac disease - sick sinus syndrome
* 2nd/3rd degree atrial ventricular block
* cardiogenic shock
* recent IV beta blocker administration
* accession bypass tract (WPW, short PR)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT05691959
Study Brief:
Protocol Section:
NCT05691959